Table of content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research & Academic Institutes Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research & Academic Institutes Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of IBS (2023)
5.2 Prescription Trends for IBS Medications (2023), by Region
5.3 Healthcare Spending on IBS Treatment, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
5.4 Emerging Therapeutic Trends in IBS Treatment
5.5 Impact of Lifestyle and Diet Trends on IBS Treatment Market
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and Promotional Activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Irritable Bowel Syndrome Treatment Market Segmentation, by Type
7.1 Chapter Overview
7.2 IBS-Cs
7.2.1 IBS-Cs Market Trends Analysis (2020-2032)
7.2.2 IBS-Cs Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 IBS-D
7.3.1 IBS-D Market Trends Analysis (2020-2032)
7.3.2 IBS-D Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Irritable Bowel Syndrome Treatment Market Segmentation, by Drug Class
8.1 Chapter Overview
8.2 Xifaxan
8.2.1 Xifaxan Market Trends Analysis (2020-2032)
8.2.2 Xifaxan Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Linzess/Constella
8.3.1 Linzess/Constella Market Trends Analysis (2020-2032)
8.3.2 Linzess/Constella Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Viberzi
8.4.1 Viberzi Market Trends Analysis (2020-2032)
8.4.2 Viberzi Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Amitiza
8.5.1 Amitiza Market Trends Analysis (2020-2032)
8.5.2 Amitiza Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Others
8.6.1 Others Market Trends Analysis (2020-2032)
8.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Irritable Bowel Syndrome Treatment Market Segmentation, by Distribution Channel
9.1 Chapter Overview
9.2 Hospital Pharmacy
9.2.1 Hospital Pharmacy Market Trends Analysis (2020-2032)
9.2.2 Hospital Pharmacy Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Retail Pharmacy
9.3.1 Retail Pharmacy Market Trends Analysis (2020-2032)
9.3.2 Retail Pharmacy Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Others
9.4.1 Others Market Trends Analysis (2020-2032)
9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.2.5 North America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.2.6.3 USA Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.2.7.3 Canada Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.2.8.3 Mexico Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.1.6.3 Poland Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.1.7.3 Romania Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.9 turkey
10.3.1.9.1 Turkey Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.5 Western Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.6.3 Germany Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.7.3 France Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.8.3 UK Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.9.3 Italy Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.10.3 Spain Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.13.3 Austria Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.4.5 Asia Pacific Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.4.6.3 China Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.4.7.3 India Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.4.8.3 Japan Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.4.9.3 South Korea Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.4.10.3 Vietnam Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.4.11.3 Singapore Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.4.12.3 Australia Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.1.5 Middle East Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.1.6.3 UAE Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.2.5 Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.6.5 Latin America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.6.6.3 Brazil Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.6.7.3 Argentina Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.6.8.3 Colombia Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Drug Class (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
11. Company Profiles
11.1 Ironwood Pharmaceuticals, Inc.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product / Services Offered
11.1.4 SWOT Analysis
11.2 Allergan
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product / Services Offered
11.2.4 SWOT Analysis
11.3 Astellas Pharma, Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product / Services Offered
11.3.4 SWOT Analysis
11.4 Takeda Pharmaceutical Company Limited
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product / Services Offered
11.4.4 SWOT Analysis
11.5 AstraZeneca
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product / Services Offered
11.5.4 SWOT Analysis
11.6 Sanofi S.A.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product / Services Offered
11.6.4 SWOT Analysis
11.7 Sebela Pharmaceuticals Inc.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product / Services Offered
11.7.4 SWOT Analysis
11.8 Bausch Health
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product / Services Offered
11.8.4 SWOT Analysis
11.9 Synthetic Biologics, Inc.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product / Services Offered
11.9.4 SWOT Analysis
11.10 Ardelyx
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product / Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
